1. Case Report: Acanthamoeba Keratitis Management in a First-trimester Pregnant Patient.
- Author
-
de Borja Domínguez-Serrano F, Caro-Magdaleno M, Perea-Pérez R, Rodríguez-de-la-Rúa E, and Montero-Iruzubieta J
- Subjects
- Acanthamoeba Keratitis diagnosis, Adult, Azithromycin therapeutic use, Benzamidines therapeutic use, Chlorhexidine therapeutic use, Combined Modality Therapy, Drug Therapy, Combination, Female, Humans, Microscopy, Confocal, Pregnancy, Pregnancy Complications, Parasitic diagnosis, Visual Acuity physiology, Acanthamoeba Keratitis therapy, Anti-Bacterial Agents therapeutic use, Antiprotozoal Agents therapeutic use, Pregnancy Complications, Parasitic therapy, Pregnancy Trimester, First, Punctal Plugs
- Abstract
Significance: Lacrimal punctal plugs may prevent the teratogenicity of the treatment used in infectious keratitis. Its use should be strongly considered in these cases., Purpose: We present the case of a 7-week pregnant patient with Acanthamoeba keratitis., Case Report: The patient was a contact lens user with photophobia, redness, and intense pain in the right eye that started 2 weeks earlier. Corrected visual acuity was 20/63 (0.5 logMAR). Biomicroscopy revealed a ciliary injection, perineural infiltrates, and corneal edema. Confocal microscopy and culture confirmed the diagnosis of Acanthamoeba keratitis. Prior to treatment with amebicidal eye drops, plugs were implanted in the lacrimal puncta to reduce the risk of drugs' teratogenicity. Three months after initiating amebicidal treatment, a melting ulcer of immunological etiology developed, which was treated with ReGeneraTing Agent eye drops, carboxymethyl glucose polysulfate (Cacicol; Théa, Clermont-Ferrand, France)., Conclusions: Lacrimal occlusion with punctal plugs is one of the available options available in cases of pregnant patients to reduce the risk of teratogenicity.
- Published
- 2018
- Full Text
- View/download PDF